Targeting of Liposomes to Solid Tumors: The Case of Sterically Stabilized Anti-Her2 Immunoliposomes
- 1 January 1997
- journal article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 7 (4) , 391-417
- https://doi.org/10.3109/08982109709035509
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding SiteJournal of Molecular Biology, 1996
- Liposomal formulations of cytotoxic drugsSupportive Care in Cancer, 1996
- Overexpression of her-2/neu in human prostate cancer and benign hyperplasiaCancer Letters, 1996
- Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivoFEBS Letters, 1991
- Tumour targeting with antibody-coupled liposomes: Failure to achieve accumulation in xenografts and spontaneous liver metastasesCancer Immunology, Immunotherapy, 1990
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990
- Drug Delivery Systems. 1. Site‐Specific Drug Delivery Using Liposomes as CarriersThe Journal of Clinical Pharmacology, 1989
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- Large unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Letters, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987